Back to the future: Extended dialysis for treatment of acute kidney injury in the intensive care unit

Journal of Nephrology

Volumn 23, Issue 5, 2010, Pages 494-501

  Kielstein, Jan T ^a   Schiffer, Mario ^a   Hafer, Carsten ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; Extended dialysis; Intensive care unit; Intermittent hemodialysis

Indexed keywords

PHOSPHATE;

ARTICLE; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; EXTENDED DAILY DIALYSIS; HEMODIALYSIS; HUMAN; HYPOPHOSPHATEMIA; INTENSIVE CARE UNIT; INTERDISCIPLINARY COMMUNICATION; INTERMETHOD COMPARISON; KIDNEY INJURY; NEPHROLOGIST; PRACTICE GUIDELINE; PROFESSIONAL KNOWLEDGE; RENAL REPLACEMENT THERAPY; SUPPLEMENTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; HUMANS; INTENSIVE CARE UNITS; RENAL DIALYSIS;

EID: 78049425129     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Centers for Disease Control. Hospitalization discharge diagnoses for kidney disease - United States, 1980-2005. MMWR. 2008;57:309-312.
2. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813-818.
3. Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 2002;30:2051-2058.
4. Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;66:1613-1621. (Pubitemid 39298397)
5. Fertmann J, Wolf H, Kuchenhoff H, Hofner B, Jauch KW, Hartl WH. Prognostic factors in critically ill surgical patients requiring continuous renal replacement therapy. J Nephrol. 2008;21:909-918.
6. Basile C. The long-term prognosis of acute kidney injury: acute renal failure as a cause of chronic kidney disease. J Nephrol. 2008;21:657-662.
7. Schortgen F, Soubrier N, Delclaux C, et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines. Am J Respir Crit Care Med. 2000;162:197-202.
8. Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis. 2004;44:1000-1007.
9. Uehlinger DE, Jakob SM, Ferrari P, et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant. 2005;20:1630-1637.
10. Najafi I, Van BW, Sharifi A, et al. Early detection of patients at high risk for acute kidney injury during disasters: development of a scoring system based on the Bam earthquake experience. J Nephrol. 2008;21:776-782.
11. Mehta RL, McDonald B, Gabbai F, et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med. 2002;113:456-461.
12. Berbece AN, Richardson RM. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int. 2006;70:963-968.
13. Fiaccadori E, Maggiore U, Rotelli C, et al. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit Care Med. 2004;32:2437-2442.
14. Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis. 2000;36:294-300.
15. Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs. 2004;27:371-379.
16. Marshall MR, Golper TA, Shaver MJ, Chatoth DK. Hybrid renal replacement modalities for the critically ill. Contrib Nephrol. 2001;132:252-257. (Pubitemid 33272479)
17. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis. 2002;39:556-570.
18. Schlaeper C, Amerling R, Manns M, Levin NW. High clearance continuous renal replacement therapy with a modified dialysis machine. Kidney Int Suppl. 1999;72:S20-S23.
19. Kielstein JT, Kretschmer U, Ernst T, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis. 2004;43:342-349.
20. Lonnemann G, Floege J, Kliem V, Brunkhorst R, Koch KM. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant. 2000;15:1189-1193.
21. Naka T, Baldwin I, Bellomo R, Fealy N, Wan L. Prolonged daily intermittent renal replacement therapy in ICU patients by ICU nurses and ICU physicians. Int J Artif Organs. 2004;27:380-387.
22. Ratanarat R, Brendolan A, Volker G, et al. Phosphate kinetics during different dialysis modalities. Blood Purif. 2005;23:83-90.
23. Czock D, Husig-Linde C, Langhoff A, et al. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol. 2006;1:1263-1268.
24. Kielstein JT, Czock D, Schopke T, et al. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med. 2006;34:51-56.
25. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int. 2001;60:777-785.
26. Marshall MR, Ma T, Galler D, Rankin AP, Williams AB. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant. 2004;19:877-884. (Pubitemid 38455659)
27. Morgera S, Scholle C, Melzer C, et al. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure. Nephron Clin Pract. 2004;98:c35-c40.
28. Schneider M, Liefeldt L, Slowinski T, Peters H, Neumayer HH, Morgera S. Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure. Int J Artif Organs. 2008;31:43-48.
29. Swoboda S, Ober MC, Lichtenstern C, et al. Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Eur J Clin Pharmacol. 2010;66:291-298.
30. Hall FS, Shaver MJ, Marshall MR. Daily 12-hour sustained low-efficiency hemodialysis (SLED): a nursing perspective [abstract]. Blood Purif. 1999;17:36A.
31. Liao Z, Zhang W, Hardy PA, et al. Kinetic comparison of different acute dialysis therapies. Artif Organs. 2003;27:802-807.
32. Moore I, Bhat R, Hoenich NA, et al. A microbiological survey of bicarbonate-based replacement circuits in continuous veno-venous hemofiltration. Crit Care Med. 2009;37:496-500.
33. Kielstein JT. [Dosage of renal replacement therapy in acute renal failure] [article in German]. Dtsch Med Wochenschr. 2009;134:1697-1699.
34. Jun M, Heerspink HJ, Ninomiya T, et al. Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2010;5:956-963.
35. Faulhaber-Walter R, Hafer C, Jahr N, et al. The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant. 2009;24:2179-2186.
36. Kielstein JT, Schwarz A, Arnavaz A, Sehlberg O, Emrich HM, Fliser D. High-flux hemodialysis: an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol. 2002;57:484-486. (Pubitemid 34625060)
37. Kielstein JT, Woywodt A, Schumann G, Haller H, Fliser D. Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication. J Toxicol Clin Toxicol. 2003;41:873-876.
38. Kielstein JT, Burkhardt O, Bode-Boeger SM. Dose matters: dose of antibiotics in the critically ill patient depends on the dose of renal replacement therapy. Crit Care Med. 2009;37:2491-2492.
39. Fiaccadori E, Parenti E, Maggiore U. Nutritional support in acute kidney injury. J Nephrol. 2008;21:645-656.
40. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627-1638.
41. Mueller BA, Pasko DA, Sowinski KM. Higher renal replacement therapy dose delivery influences on drug therapy. Artif Organs. 2003;27:808-814.
42. Burkhardt O, Hafer C, Langhoff A, et al. Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrol Dial Transplant. 2009;24:267-271.
43. Czock D, Husig-Linde C, Langhoff A, et al. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol. 2006;1:1263-1268.
44. Kielstein JT, Czock D, Schopke T, et al. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis. Crit Care Med. 2006;34:51-56.
45. Kielstein JT, Eugbers C, Bode-Boeger SM, et al. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis - a pharmacokinetic study. Nephrol Dial Transplant. 2010;25:1537-1541.
46. Alam M, Marshall M, Shaver M, Chatoth D. Cost comparison between sustained low efficiency hemodialysis (SLED) and continuous venovenous hemofiltration (CVVH) for ICU patients with ARF [abstract]. Am J Kidney Dis. 2000;35:A9.